Cargando…
Actionable pharmacogenetic markers for prediction and prognosis in breast cancer
Breast cancer is a heterogeneous disease that necessitates proper patient classification to direct surgery, pharmacotherapy, and radiotherapy. Despite patients within the same subgroup receiving similar pharmacotherapy, substantial variation in clinical outcomes is observed. Pharmacogenetic variatio...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511448/ https://www.ncbi.nlm.nih.gov/pubmed/26203310 http://dx.doi.org/10.1186/s13167-015-0037-z |